Novorapid and Scratch - a phase IV clinical study of FDA data

Summary:

Scratch is reported as a side effect among people who take Novorapid (insulin aspart recombinant), especially for people who are male, 60+ old, also take Toradol, and have Pneumonia.

The phase IV clinical study analyzes which people have Scratch when taking Novorapid. It is created by eHealthMe based on reports of 24,590 people who have side effects when taking Novorapid from the FDA, and is updated regularly.

What is Novorapid?

Novorapid has active ingredients of insulin aspart recombinant. It is often used in type 1 diabetes. eHealthMe is studying from 24,730 Novorapid users. Check the latest studies of Novorapid.

What is Scratch?

Scratch is found to be associated with 693 drugs and 745 conditions by eHealthMe. Check the latest studies of Scratch.

On Jul, 12, 2026

24,590 people reported to have side effects when taking Novorapid.
Among them, 19 people (0.08%) have Scratch.

Among these 19 people:

What is the gender of people who have Scratch when taking Novorapid? *

female: 22.22 %
male: 77.78 %

What is the age of people who have Scratch when taking Novorapid? *

What are other drugs people take besides Novorapid? *

What are other side effects people have besides Scratch? *

Itching: 18 people, 94.74%
Rashes (redness): 13 people, 68.42%
Peripheral Swelling: 11 people, 57.89%
Blood Glucose Decreased: 10 people, 52.63%
Hyperhidrosis (abnormally increased sweating): 10 people, 52.63%
Night Sweats (sweating in night): 10 people, 52.63%
Nausea And Vomiting: 10 people, 52.63%
Nausea (feeling of having an urge to vomit): 10 people, 52.63%
Nasopharyngitis (inflammation of the nasopharynx): 10 people, 52.63%
Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 10 people, 52.63%

What are the existing conditions these people have? *

Urticaria (rash of round, red welts on the skin that itch intensely): 10 people, 52.63%
Pneumonia: 10 people, 52.63%
Psoriasis (immune-mediated disease that affects the skin): 6 people, 31.58%
Pain In Extremity: 3 people, 15.79%
Neuropathy Peripheral (surface nerve damage): 3 people, 15.79%
Indigestion: 3 people, 15.79%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 10.53%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 5.26%
Lung Cancer - Non-Small Cell (lung cancer): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Novorapid and have Scratch?

- Check whether Scratch is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Novorapid:

Novorapid (24,730 reports)

Scratch treatments and more:

Scratch (10,633 reports)

Browse all side effects of Novorapid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Scratch:

Scratch (693 drugs)

Browse all the conditions that are associated with Scratch:

Scratch (745 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on insulin aspart recombinant (the active ingredients of Novorapid) and Novorapid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.